View Clinical Trial (Medical Research Study)

Risk Stratification of Rapid Disease Progression in Children With Crohn's Disease - NCT00790543-43205(Clinical Trial 641294)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Columbus
State:  
OH
Zip Code: 43205
Conditions: Crohn's Disease
Purpose: The purpose of this study for children with a new diagnosis of Crohn's disease is to identify biomarkers found in the blood or stool to help predict which children are at risk of developing complications.
Study summary: It is estimated that between 15-20% of children with Crohn's disease will develop complications that can require surgery within the first three years of diagnosis. The purpose of this study for children with a new diagnosis of Crohn's disease is to identify biomarkers found in the blood or stool to help predict which children are at risk of developing complications. A total of 1100 children with newly-diagnosed Crohn's disease will be enrolled within 30 days of diagnosis. Up to 50 medical sites in the United States and Canada will participate in the study.
Criteria: Inclusion Criteria: - Males and females younger than 17 years of age (before their 17th birthday). An upper limit of 17 years of age was selected as important inclusion criteria to maximize the number of potential subjects that would be diagnosed and followed by a pediatric gastroenterologist for at least 3 years. - Confirmed or suspected diagnosis of Crohn's disease based on standardized diagnostic criteria. The enrollment should occur within 30 days of diagnosis. - Able to provide written informed consent or the ability to obtain written informed consent from the parents or patient's legal guardian in conjunction with youth assent. - Consented to have specimens tested for genetics and immune responses. - Access to follow-up data for a minimum of 36 months after diagnosis. - Final eligibility will be determined by the health professionals conducting this clinical trial. Exclusion Criteria: - Infectious colitis. - Final eligibility will be determined by the health professionals conducting this clinical trial.
Study is available at: Nationwide Children's Hospital
Columbus, OH 43205
United States

Primary Contact:
Stacy Ballam
Email: stacy.ballam@nationwidechildrens.org
Phone: 614-722-3004

Secondary Contact:
Subra Kugathasan, MD
Email: skugath@emory.edu
Phone: 404-727-4542
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.